KAREN CHAVEZ-JONES: Open Payments
NPI 1538713649 · KENNER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$792 in 16 payments from 8 companies in 2025. Trend: 2023 $775 · 2024 $765 · 2025 $792
Food & beverage: $792
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $245 |
| Dexcom, Inc. | 2 | $167 |
| Abbott Laboratories | 1 | $163 |
| Gilead Sciences, Inc. | 5 | $109 |
| Organon LLC | 2 | $42 |
| PFIZER INC. | 2 | $34 |
| Lilly USA, LLC | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $15 |
Products named: DEXCOM G7 GSS (161), FREESTYLE LIBRE 3, AUSTEDO XR, UZEDY, NEXPLANON, PREVNAR 20, MOUNJARO, NEXLETOL.
Industry payments across LA — which companies pay providers there.
